GGrantIndex
← Leaderboards

Jeffrey R. Curtis

University Of Alabama At Birmingham

$9,424,518
Attributed
$11,054,141
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,184,482 · 9
AHRQ$2,166,338 · 1

By mechanism

P30$5,812,594 · 4
UM1$3,112,747 · 1
R01$2,166,338 · 1
P50$1,845,951 · 1
P60$1,511,750 · 1
K23$754,940 · 1

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseDesignResourcesTechnologyRheumatologyEpidemiologyCaringFutureResearch PersonnelFundingRheumatismElectronic Health RecordCommunitiesInnovationInformaticsLinkClinical ResearchHealth TechnologyTranslational ResearchRegistriesDevicesChronicComorbidityCollection

Grant awards (39)

Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$617,596
P30 · FY2025 · AR · contact PI
Administrative Core$205,867
P30 · FY2025 · AR · contact PI
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$696,082
P30 · FY2024 · AR · contact PI
Administrative Core$257,887
P30 · FY2024 · AR · contact PI
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$742,719
P30 · FY2023 · AR · contact PI
Administrative Core$266,353
P30 · FY2023 · AR · contact PI
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$742,719
P30 · FY2022 · AR · contact PI
Administrative Core$266,353
P30 · FY2022 · AR · contact PI
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$748,415
P30 · FY2021 · AR · contact PI
Administrative Core$266,355
P30 · FY2021 · AR · contact PI
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)$749,148
P30 · FY2020 · AR · contact PI
Administrative Core$253,100
P30 · FY2020 · AR · contact PI
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)$654,455
UM1 · FY2019 · AR · contact PI
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)$614,070
UM1 · FY2018 · AR · contact PI
Facilitating Treat-to-Target Using Novel Health Technology with Decision support$301,164
P60 · FY2017 · AR · contact PI
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)$612,746
UM1 · FY2016 · AR · contact PI
A Novel Centralized Virtual Gout Clinic for Chronic Gout Management$341,660
P50 · FY2016 · AR · contact PI
Facilitating Treat-to-Target Using Novel Health Technology with Decision support$313,959
P60 · FY2016 · AR · contact PI
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)$606,509
UM1 · FY2015 · AR · contact PI
Facilitating Treat-to-Target Using Novel Health Technology with Decision support$298,820
P60 · FY2015 · AR · contact PI
A Novel Centralized Virtual Gout Clinic for Chronic Gout Management$293,980
P50 · FY2015 · AR · contact PI
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)$624,967
UM1 · FY2014 · AR · contact PI
A Novel Centralized Virtual Gout Clinic for Chronic Gout Management$395,453
P50 · FY2014 · AR · contact PI
Facilitating Treat-to-Target Using Novel Health Technology with Decision support$283,590
P60 · FY2014 · AR · contact PI
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity$449,835
R01 · FY2013 · HS · contact PI
A Novel Centralized Virtual Gout Clinic for Chronic Gout Management$432,400
P50 · FY2013 · AR · contact PI
Facilitating Treat-to-Target Using Novel Health Technology with Decision support$314,217
P60 · FY2013 · AR · contact PI
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity$448,576
R01 · FY2012 · HS · contact PI
A Novel Centralized Virtual Gout Clinic for Chronic Gout Management$382,458
P50 · FY2012 · AR · contact PI
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity$447,785
R01 · FY2011 · HS · contact PI
The TAKEOFF Trial: Clinical Trial Planning Grant$146,500
R34 · FY2011 · AR · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$129,708
K23 · FY2011 · AR · contact PI
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity$430,802
R01 · FY2010 · HS · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$129,708
K23 · FY2010 · AR · contact PI
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity$389,340
R01 · FY2009 · HS · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$129,708
K23 · FY2009 · AR · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$108,000
K23 · FY2009 · AR · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$128,908
K23 · FY2008 · AR · contact PI
Ethnic Differences in the Risk of Fracture and Vascular Disease$128,908
K23 · FY2007 · AR · contact PI